JPS5437136B2 - - Google Patents

Info

Publication number
JPS5437136B2
JPS5437136B2 JP11707976A JP11707976A JPS5437136B2 JP S5437136 B2 JPS5437136 B2 JP S5437136B2 JP 11707976 A JP11707976 A JP 11707976A JP 11707976 A JP11707976 A JP 11707976A JP S5437136 B2 JPS5437136 B2 JP S5437136B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP11707976A
Other versions
JPS5242872A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5242872A publication Critical patent/JPS5242872A/ja
Publication of JPS5437136B2 publication Critical patent/JPS5437136B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
JP51117079A 1975-09-29 1976-09-29 Novel homologue of natural prostaglandine Granted JPS5242872A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/617,481 US4065472A (en) 1975-09-29 1975-09-29 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins

Publications (2)

Publication Number Publication Date
JPS5242872A JPS5242872A (en) 1977-04-04
JPS5437136B2 true JPS5437136B2 (ja) 1979-11-13

Family

ID=24473823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51117079A Granted JPS5242872A (en) 1975-09-29 1976-09-29 Novel homologue of natural prostaglandine

Country Status (11)

Country Link
US (1) US4065472A (ja)
JP (1) JPS5242872A (ja)
BE (1) BE846650A (ja)
CA (1) CA1085832A (ja)
DE (1) DE2640692C3 (ja)
DK (1) DK435276A (ja)
FR (1) FR2325371A1 (ja)
GB (1) GB1508925A (ja)
IE (1) IE44067B1 (ja)
LU (1) LU75904A1 (ja)
NL (1) NL7610761A (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
UA99840C2 (ru) * 2007-11-09 2012-10-10 Аллерган, Инк. Замещенные циклопентаны, которые имеют простагландиновую активность

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1350971A (en) 1971-05-11 1974-04-24 Imp Chemi Als Ind Ltd Cyclopentane derivatives
US3922289A (en) * 1973-02-23 1975-11-25 Syntex Inc Trans-prostaglandin-like compounds and methods

Also Published As

Publication number Publication date
DE2640692B2 (ja) 1979-01-18
IE44067B1 (en) 1981-08-12
LU75904A1 (ja) 1977-05-11
FR2325371B1 (ja) 1978-12-22
US4065472A (en) 1977-12-27
IE44067L (en) 1977-03-29
CA1085832A (en) 1980-09-16
GB1508925A (en) 1978-04-26
JPS5242872A (en) 1977-04-04
NL7610761A (nl) 1977-03-31
DK435276A (da) 1977-03-30
DE2640692C3 (de) 1979-09-13
FR2325371A1 (fr) 1977-04-22
BE846650A (fr) 1977-03-28
DE2640692A1 (de) 1977-03-31

Similar Documents

Publication Publication Date Title
FR2308193B1 (ja)
JPS5249420U (ja)
JPS554783Y2 (ja)
CS177686B1 (ja)
JPS5292295U (ja)
JPS51128007U (ja)
JPS51132502U (ja)
JPS5217614U (ja)
CH594203A5 (ja)
CH588069A5 (ja)
CH606712A5 (ja)
CH576092A5 (ja)
CH601833A5 (ja)
CH599497A5 (ja)
CH588401A5 (ja)
CH608067A5 (ja)
CH597501A5 (ja)
CH602916A5 (ja)
BG21435A1 (ja)
CH613161A5 (ja)
CH600357A5 (ja)
CH607072A5 (ja)
LU75904A1 (ja)
BG21162A1 (ja)
CH597482A5 (ja)